96 results
Page 3 of 5
6-K
EX-99.1
wfdcfmqe te5
11 Aug 21
BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights
8:00am
6-K
EX-99.1
1d4dfgprr
2 Jun 21
BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC
8:00am
6-K
EX-99.1
jgbksdprvjtqno6
1 Jun 21
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor
8:00am
6-K
EX-99.1
oirgp
24 May 21
Current report (foreign)
8:00am
6-K
EX-99.1
mq2i rojxa9hvitp
24 May 21
BrainsWay Updates Line Item in 2021 First Quarter Financial Results
7:30am
6-K
EX-99.1
bi490g02v rp7j84
20 May 21
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
8:00am
6-K
EX-99.1
p5bdy 35b
5 May 21
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
8:00am
SC TO-I
EX-99
oda2il1eg2kx0psq
4 May 21
Issuer tender offer statement
9:28am
SC TO-I
EX-99
xvl1zizn9uhnlb7si xd
4 May 21
Issuer tender offer statement
9:28am
SC TO-I
EX-99
2t0j1xqd77qshobs
4 May 21
Issuer tender offer statement
9:28am
6-K
EX-99.1
qo8bxtzwq j2rm
26 Apr 21
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder
7:30am
6-K
EX-99.1
o5ugw2
24 Mar 21
BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights
4:15pm
6-K
EX-1.1
ifg1 5da9fwn0lo
25 Feb 21
Current report (foreign)
11:00am
424B5
cej twdtswv82727ukez
24 Feb 21
Prospectus supplement for primary offering
4:31pm
424B5
wcn8ktw
22 Feb 21
Prospectus supplement for primary offering
5:08pm
6-K
EX-99.1
dnnotgagsy1mh1t
18 Nov 20
BrainsWay Reports Third Quarter 2020 Financial Results and Operational Highlights
7:00am
6-K
EX-99.1
d03gq3qn96rpbj
4 Nov 20
Current report (foreign)
7:00am
F-3
o2t5n5b1j d7usd9pd
4 Sep 20
Shelf registration (foreign)
9:37am
6-K
EX-99.1
miyta9og
12 Aug 20
BrainsWay Reports Second Quarter 2020 Financial Results and Operational Highlights
7:09am